IN156105B - - Google Patents

Info

Publication number
IN156105B
IN156105B IN308/CAL/82A IN308CA1982A IN156105B IN 156105 B IN156105 B IN 156105B IN 308CA1982 A IN308CA1982 A IN 308CA1982A IN 156105 B IN156105 B IN 156105B
Authority
IN
India
Application number
IN308/CAL/82A
Other languages
English (en)
Inventor
Eralodo Borgo
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of IN156105B publication Critical patent/IN156105B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN308/CAL/82A 1980-04-18 1982-03-19 IN156105B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (1)

Publication Number Publication Date
IN156105B true IN156105B (fr) 1985-05-18

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
IN308/CAL/82A IN156105B (fr) 1980-04-18 1982-03-19

Country Status (15)

Country Link
US (1) US4386077A (fr)
AT (1) AT376366B (fr)
AU (1) AU544469B2 (fr)
BE (1) BE890796A (fr)
CH (1) CH652026A5 (fr)
DE (1) DE3115080C2 (fr)
DK (1) DK173081A (fr)
ES (1) ES502080A0 (fr)
FR (1) FR2480603B1 (fr)
GB (1) GB2074445B (fr)
IN (1) IN156105B (fr)
IT (1) IT1207106B (fr)
NL (1) NL8101899A (fr)
SE (1) SE447449B (fr)
ZA (1) ZA812600B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (fr) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. Composition pharmaceutique
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
CA2094217A1 (fr) * 1992-04-17 1993-10-18 Yasutaka Igari Composition therapeutique transmucosale
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
WO1996027380A1 (fr) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction de l'ampleur des infarctus par la citicoline
US8030294B2 (en) * 2000-03-16 2011-10-04 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US20060189566A1 (en) * 2003-02-26 2006-08-24 Miho Komatsu Muscle building agent and preventive or remedy for muscle weakening
WO2005122767A1 (fr) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, notamment de l'uridine, utilisees dans des traitements sur des patients atteints de troubles bipolaires
EP1765364A4 (fr) * 2004-06-10 2010-09-22 Mclean Hospital Corp Pyrimidines, tels que cytidine, dans les traitements de patients souffrant de troubles bipolaires
WO2006020703A1 (fr) * 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compose pour le traitement de la dependance, de la suppression et de l'usage de la marijuana
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (fr) * 1969-08-04 1973-12-07
JPS4886869A (fr) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
AU544469B2 (en) 1985-05-30
DK173081A (da) 1981-10-19
GB2074445B (en) 1983-09-07
ES8207184A1 (es) 1982-09-01
DE3115080A1 (de) 1982-02-25
ES502080A0 (es) 1982-09-01
IT1207106B (it) 1989-05-17
AT376366B (de) 1984-11-12
ZA812600B (en) 1982-04-28
FR2480603A1 (fr) 1981-10-23
SE8102456L (sv) 1981-10-19
FR2480603B1 (fr) 1985-07-12
GB2074445A (en) 1981-11-04
BE890796A (fr) 1982-02-15
ATA172081A (de) 1984-04-15
CH652026A5 (it) 1985-10-31
NL8101899A (nl) 1981-11-16
IT8048454A0 (it) 1980-04-18
SE447449B (sv) 1986-11-17
AU6994581A (en) 1981-10-22
DE3115080C2 (de) 1986-10-16
US4386077A (en) 1983-05-31

Similar Documents

Publication Publication Date Title
DE3125260C2 (fr)
FR2475511B1 (fr)
FR2474270B1 (fr)
DE3111126C2 (fr)
FR2488579B1 (fr)
DE3142820C2 (fr)
DE3041938C2 (fr)
FR2473056B1 (fr)
DE3134792C2 (fr)
GR75102B (fr)
GR74866B (fr)
FR2473810B1 (fr)
CH627610GA3 (fr)
FR2473237B1 (fr)
FR2474848B1 (fr)
FR2474265B1 (fr)
DE3140503C2 (fr)
DE3131407C2 (fr)
DE3127197C2 (fr)
DE3144406T1 (fr)
FR2473852B1 (fr)
IN156105B (fr)
FR2474368B1 (fr)
FR2475380B1 (fr)
FR2475180B1 (fr)